INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

54 hedge funds and large institutions have $379M invested in Inozyme Pharma in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 7 reducing their positions, and 10 closing their positions.

Holders
54
Holders Change
+1
Holders Change %
+1.89%
% of All Funds
0.96%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
11
Increased
20
Reduced
7
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PBPIA
1
Pivotal bioVenture Partners Investment Advisor
California
$32.8M
2
SCM
2
Suvretta Capital Management
New York
$4.42M
3
BCM
3
Burrage Capital Management
Massachusetts
$3.53M
4
Wellington Management Group
4
Wellington Management Group
Massachusetts
$9.06M
5
BlackRock
5
BlackRock
New York
$13M

Top Sellers

1
SFM
1
Sphera Funds Management
Israel
$0
2
APM
2
Avidity Partners Management
Texas
$200K
3
RSCM
3
Rock Springs Capital Management
Maryland
$17.1M
4
MF
4
Magnetar Financial
Illinois
$0
5
Marshall Wace
5
Marshall Wace
United Kingdom
$0
Name Market Value Shares Shares
Change 		Shares
Change %
NHAS
1
Novo Holdings A/S
Denmark
$53M 2,569,379 – –
NMC
2
NEA Management Company
Maryland
$50.5M 2,444,379 – –
SI
3
Sofinnova Investments
California
$41.9M 2,028,308 – –
RCM
4
RA Capital Management
Massachusetts
$41.4M 2,003,653 – –
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$32.8M 1,591,154 +1,591,154 New
DM
6
Deerfield Management
New York
$23.7M 1,150,299 – –
CA
7
CHI Advisors
New York
$20.5M 995,396 -13,721 -1%
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
$18.5M 896,672 +96,672 +12%
RSCM
9
Rock Springs Capital Management
Maryland
$17.1M 830,546 -49,408 -6%
BlackRock
10
BlackRock
New York
$13M 630,751 +129,817 +26%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$12.6M 609,380 – –
Wellington Management Group
12
Wellington Management Group
Massachusetts
$9.06M 438,703 +134,012 +44%
O
13
OrbiMed
New York
$8.26M 400,400 – –
Vanguard Group
14
Vanguard Group
Pennsylvania
$6.38M 309,114 +12,077 +4%
Citadel Advisors
15
Citadel Advisors
Florida
$5.21M 252,542 +11,464 +5%
SCM
16
Suvretta Capital Management
New York
$4.42M 214,311 +214,311 New
BCM
17
Burrage Capital Management
Massachusetts
$3.53M 170,796 +170,796 New
State Street
18
State Street
Massachusetts
$2.43M 117,579 +46,994 +67%
YU
19
Yale University
Connecticut
$2.34M 113,502 – –
BBA
20
Baker Bros. Advisors
New York
$2.21M 106,999 -11,501 -10%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$2.2M 106,446 +8,162 +8%
Northern Trust
22
Northern Trust
Illinois
$1.92M 92,806 +42 +0%
Charles Schwab
23
Charles Schwab
California
$1.01M 49,045 +711 +1%
Bank of New York Mellon
24
Bank of New York Mellon
New York
$440K 21,349 +1,964 +10%
Nuveen Asset Management
25
Nuveen Asset Management
Illinois
$439K 21,292 +4,222 +25%
1
2 3